Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death
暂无分享,去创建一个
J. Correale | G. Rabinovich | J. Ilarregui | M. Toscano | E. Riley | L. Baum | Linda G Baum | Gabriel A Rabinovich | F. Poirier | Norberto W Zwirner | Eleanor M Riley | N. Zwirner | Jorge Correale | Francoise Poirier | Marta A Toscano | Germán A Bianco | Juan M Ilarregui | Diego O Croci | Joseph D Hernandez | G. A. Bianco | Joseph D. Hernandez | D. Croci | Germán A. Bianco
[1] J. Ravetch,et al. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.
[2] R. Coffman. Origins of the T(H)1-T(H)2 model: a personal perspective. , 2006, Nature immunology.
[3] S. Stowell,et al. Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. , 2003, Glycobiology.
[4] F. Luscinskas,et al. β‐Galactoside α2,3‐sialyltransferase‐I gene expression during Th2 but not Th1 differentiation: implications for core2‐glycan formation on cell surface proteins , 2002 .
[5] Christina Bitegye,et al. Early Events of TCR Signaling Are Distinct in Human Th1 and Th2 Cells , 2002, The Journal of Immunology.
[6] G. Rabinovich,et al. Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis , 1999, The Journal of experimental medicine.
[7] Stefano Iacobelli,et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.
[8] Lawrence Steinman,et al. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[9] Toshihiko Oka,et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. , 2002, Biochimica et biophysica acta.
[10] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[11] J. Marth,et al. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Hirabayashi,et al. Systematic comparison of oligosaccharide specificity of Ricinus communis agglutinin I and Erythrina lectins: a search by frontal affinity chromatography. , 2007, Journal of biochemistry.
[13] G. Rabinovich,et al. Galectin-1 suppresses experimental colitis in mice. , 2003, Gastroenterology.
[14] S. Tsuboi,et al. Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1* , 2000, The Journal of Biological Chemistry.
[15] Kristin A. Hogquist,et al. Sweet 'n' sour: the impact of differential glycosylation on T cell responses , 2002, Nature Immunology.
[16] H. Pircher,et al. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. , 1998, European journal of immunology.
[17] L. Baum,et al. Apoptosis of T cells mediated by galectin-1 , 1995, Nature.
[18] J. Dennis,et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.
[19] J. Marth,et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment , 2007, Nature Immunology.
[20] R. Kannagi,et al. Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes , 2006, Proceedings of the National Academy of Sciences.
[21] V. Kuchroo,et al. TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.
[22] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[23] A. van den Berg,et al. Strongly enhanced IL-10 production using stable galectin-1 homodimers. , 2007, Molecular immunology.
[24] L. Baum,et al. The ST6Gal I Sialyltransferase Selectively ModifiesN-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death* , 2003, The Journal of Biological Chemistry.
[25] L. Glimcher,et al. Lineage commitment in the immune system: the T helper lymphocyte grows up. , 2000, Genes & development.
[26] R. Coffman. Origins of the TH1-TH2 model: a personal perspective , 2006, Nature Immunology.
[27] R. Lechler,et al. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.
[28] L. Hennighausen,et al. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.
[29] B. Pulendran. Modulating Th1/Th2 responses with microbes, dendritic cells, and pathogen recognition receptors , 2004, Immunologic research.
[30] F. Luscinskas,et al. IL-12, STAT4-Dependent Up-Regulation of CD4+ T Cell Core 2 β-1,6-n-Acetylglucosaminyltransferase, an Enzyme Essential for Biosynthesis of P-Selectin Ligands1 , 2001, The Journal of Immunology.
[31] R. Handgretinger,et al. Increased α2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells , 2006 .
[32] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[33] E. Pearce,et al. Cutting Edge: Dendritic Cells Copulsed with Microbial and Helminth Antigens Undergo Modified Maturation, Segregate the Antigens to Distinct Intracellular Compartments, and Concurrently Induce Microbe-Specific Th1 and Helminth-Specific Th2 Responses 1 , 2004, The Journal of Immunology.
[34] D. Hsu,et al. Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death1 , 2006, The Journal of Immunology.
[35] J. Dennis,et al. N-Acetylglucosaminyltransferase V (Mgat5)-Mediated N-Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells1 , 2004, The Journal of Immunology.
[36] D. G. Zisoulis,et al. A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells. , 2005, Blood.
[37] E. Robertson,et al. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. , 1993, Development.
[38] J. Marth,et al. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. , 2000, Immunity.
[39] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[40] L. Hennighausen,et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.
[41] Y. Kooyk,et al. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45 , 2006, Nature Immunology.
[42] DavidE . Goldberg,et al. Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 , 2006, The Journal of Immunology.
[43] J. Altman,et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. , 2001, Immunity.
[44] D. Green,et al. Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis , 1997, The Journal of experimental medicine.
[45] L. A. Lewis,et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. , 1999, Journal of immunology.
[46] T. Bringman,et al. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis , 1990, Journal of Neuroimmunology.
[47] J. Marth,et al. Sialylation regulates peripheral tolerance in CD4+ T cells. , 2006, International immunology.
[48] Mariano J. Alvarez,et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. , 2004, Cancer cell.
[49] R. D. Hatton,et al. Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.
[50] R. J. Hocking,et al. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease , 2006, Nature Immunology.
[51] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[52] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[53] Hans-Joachim Gabius,et al. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. , 2006, Critical reviews in immunology.
[54] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.